These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 23187835)
21. Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Iacobuzio-Donahue CA Gut; 2012 Jul; 61(7):1085-94. PubMed ID: 21749982 [TBL] [Abstract][Full Text] [Related]
22. Genetic progression of pancreatic cancer. Cowan RW; Maitra A Cancer J; 2014; 20(1):80-4. PubMed ID: 24445769 [TBL] [Abstract][Full Text] [Related]
23. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities. Lüttges J; Klöppel G Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Hong SM; Vincent A; Kanda M; Leclerc J; Omura N; Borges M; Klein AP; Canto MI; Hruban RH; Goggins M Clin Cancer Res; 2012 Aug; 18(16):4303-12. PubMed ID: 22723370 [TBL] [Abstract][Full Text] [Related]
25. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Hanlon L; Avila JL; Demarest RM; Troutman S; Allen M; Ratti F; Rustgi AK; Stanger BZ; Radtke F; Adsay V; Long F; Capobianco AJ; Kissil JL Cancer Res; 2010 Jun; 70(11):4280-6. PubMed ID: 20484026 [TBL] [Abstract][Full Text] [Related]
26. Molecular Diagnostics in the Evaluation of Pancreatic Cysts. Theisen BK; Wald AI; Singhi AD Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971 [TBL] [Abstract][Full Text] [Related]
27. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Iacobuzio-Donahue CA; Velculescu VE; Wolfgang CL; Hruban RH Clin Cancer Res; 2012 Aug; 18(16):4257-65. PubMed ID: 22896692 [TBL] [Abstract][Full Text] [Related]
28. Molecular alterations in pancreatic tumors. Visani M; Acquaviva G; De Leo A; Sanza V; Merlo L; Maloberti T; Brandes AA; Franceschi E; Di Battista M; Masetti M; Jovine E; Fiorino S; Pession A; Tallini G; de Biase D World J Gastroenterol; 2021 Jun; 27(21):2710-2726. PubMed ID: 34135550 [TBL] [Abstract][Full Text] [Related]
30. New insights into pancreatic cancer biology. Hidalgo M Ann Oncol; 2012 Sep; 23 Suppl 10():x135-8. PubMed ID: 22987949 [TBL] [Abstract][Full Text] [Related]
31. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas. Tulla KA; Maker AV Langenbecks Arch Surg; 2018 Mar; 403(2):151-194. PubMed ID: 29218397 [TBL] [Abstract][Full Text] [Related]
32. Molecular pathology of pancreatic cancer. Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Nakamoto M; Hisaoka M J UOEH; 2016 Mar; 38(1):1-8. PubMed ID: 26972939 [TBL] [Abstract][Full Text] [Related]
34. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes. Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378 [TBL] [Abstract][Full Text] [Related]
35. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype? Chandana S; Mahadevan D Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723 [TBL] [Abstract][Full Text] [Related]